Latest News and Press Releases
Want to stay updated on the latest news?
-
PHILADELPHIA, April 14, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA , April 11, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, April 08, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, April 07, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, April 04, 2025 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (NASDAQ: ARQQ) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Axsome Therapeutics, Inc....
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 29, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Axsome Therapeutics, Inc....
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 13, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Axsome Therapeutics, Inc....
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 02, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Axsome Therapeutics, Inc....
-
SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that...